- Home
- GBTG vs VKTX Comparison
GBTG vs VKTX Comparison
Compare GBTG & VKTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GBTG
- VKTX
- Stock Information
- Founded
- GBTG 2014
- VKTX 2012
- Country
- GBTG United States
- VKTX United States
- Employees
- GBTG N/A
- VKTX N/A
- Industry
- GBTG Computer Software: Prepackaged Software
- VKTX Biotechnology: Pharmaceutical Preparations
- Sector
- GBTG Technology
- VKTX Health Care
- Exchange
- GBTG Nasdaq
- VKTX Nasdaq
- Market Cap
- GBTG 3.2B
- VKTX 2.8B
- IPO Year
- GBTG N/A
- VKTX 2015
- Fundamental
- Price
- GBTG $6.01
- VKTX $27.85
- Analyst Decision
- GBTG Strong Buy
- VKTX Buy
- Analyst Count
- GBTG 4
- VKTX 12
- Target Price
- GBTG $9.63
- VKTX $84.00
- AVG Volume (30 Days)
- GBTG 848.4K
- VKTX 4.4M
- Earning Date
- GBTG 05-06-2025
- VKTX 04-23-2025
- Dividend Yield
- GBTG N/A
- VKTX N/A
- EPS Growth
- GBTG N/A
- VKTX N/A
- EPS
- GBTG N/A
- VKTX N/A
- Revenue
- GBTG $2,434,000,000.00
- VKTX N/A
- Revenue This Year
- GBTG $6.97
- VKTX N/A
- Revenue Next Year
- GBTG $5.86
- VKTX N/A
- P/E Ratio
- GBTG N/A
- VKTX N/A
- Revenue Growth
- GBTG 4.82
- VKTX N/A
- 52 Week Low
- GBTG $5.30
- VKTX $18.92
- 52 Week High
- GBTG $9.60
- VKTX $81.81
- Technical
- Relative Strength Index (RSI)
- GBTG 30.00
- VKTX 54.95
- Support Level
- GBTG $5.90
- VKTX $26.73
- Resistance Level
- GBTG $6.97
- VKTX $30.28
- Average True Range (ATR)
- GBTG 0.21
- VKTX 1.66
- MACD
- GBTG -0.03
- VKTX 0.37
- Stochastic Oscillator
- GBTG 10.23
- VKTX 65.19
About GBTG Global Business Travel Group Inc.
Global Business Travel Group Inc operates as a business-to-business travel platform. It is engaged in providing software and services to manage travel, expenses, and meetings and events for companies of all sizes. The company is engaged in building the marketplace in B2B travel to deliver unrivaled choice, value, and experiences. It also provides business travel solutions, simplified travel management, and business consulting services. Further, The company generates revenue in two ways that involves fees and other revenues relating to processing and servicing travel transactions received from clients and travel suppliers and revenues for the provision of products and professional services not directly related to transactions received from clients, travel suppliers and Network Partners.
About VKTX Viking Therapeutics Inc.
Viking Therapeutics Inc is a healthcare service provider. The company specializes in the area of biopharmaceutical development focused on metabolic and endocrine disorders. The company's clinical program pipeline consists of VK2809, VK5211, VK0214 products. VK2809 and VK0214 are orally available, tissue and receptor-subtype selective agonists of the thyroid hormone receptor beta. VK5211 is an orally available, non-steroidal selective androgen receptor modulator.